Products Overview
FoxHollow develops and distributes breakthrough minimally invasive technologies for the treatment of peripheral arterial disease (PAD). PAD results from plaque that accumulates in the arteries and limits blood flow in the legs. The need to improve both immediate and long-term patient outcomes, while minimizing the need for amputation and bypass surgery, helps drive FoxHollow’s vision and product lines.
FoxHollow manufactures and sells three commercially available product lines – the SilverHawk® Plaque Excision System for the removal of arterial plaque, the Rinspirator Thrombus Removal System for the removal of thrombi and debris and the Sheath for vascular access.
GET INFO
on FoxHollow’s commercially available products
on FoxHollow’s commercially available products
LEARN ABOUT
the SilverHawk, the only FDA-cleared device for removing plaque from peripheral arteries
the SilverHawk, the only FDA-cleared device for removing plaque from peripheral arteries
Technical Innovation
The Company is also continuously expanding and developing new product technologies for both its current and future product lines.LEARN MORE
about FoxHollow’s focus on technical innovation
about FoxHollow’s focus on technical innovation